These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 16965694

  • 21. Cancer vaccines. Part 2.
    Hallin PA, Adams VR.
    J Am Pharm Assoc (Wash); 1997; NS37(6):706-9. PubMed ID: 9425801
    [Abstract] [Full Text] [Related]

  • 22. Breast cancer vaccines: promise for the future or pipe dream?
    Mittendorf EA, Peoples GE, Singletary SE.
    Cancer; 2007 Oct 15; 110(8):1677-86. PubMed ID: 17763371
    [Abstract] [Full Text] [Related]

  • 23. Developments in cancer vaccination.
    Lysaght J, Todryk S.
    Curr Opin Investig Drugs; 2003 Jun 15; 4(6):716-21. PubMed ID: 12901231
    [Abstract] [Full Text] [Related]

  • 24. Vaccine therapy for renal cancer.
    Amato RJ.
    Expert Rev Vaccines; 2008 Sep 15; 7(7):925-35. PubMed ID: 18767943
    [Abstract] [Full Text] [Related]

  • 25. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 15; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 26. Multipeptide vaccination in cancer patients.
    Pilla L, Rivoltini L, Patuzzo R, Marrari A, Valdagni R, Parmiani G.
    Expert Opin Biol Ther; 2009 Aug 15; 9(8):1043-55. PubMed ID: 19591629
    [Abstract] [Full Text] [Related]

  • 27. Novel approaches to therapeutic cancer vaccines.
    Hellstrom KE, Hellstrom I.
    Expert Rev Vaccines; 2003 Aug 15; 2(4):517-32. PubMed ID: 14711336
    [Abstract] [Full Text] [Related]

  • 28. Technical challenges facing therapeutic cancer vaccines.
    Ward S, Copier J, Dalgleish A.
    Curr Opin Drug Discov Devel; 2008 Mar 15; 11(2):168-77. PubMed ID: 18283604
    [Abstract] [Full Text] [Related]

  • 29. Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: a safety study.
    Ovali E, Dikmen T, Sonmez M, Yilmaz M, Unal A, Dalbasti T, Kuzeyli K, Erturk M, Omay SB.
    J Exp Clin Cancer Res; 2007 Jun 15; 26(2):209-14. PubMed ID: 17725100
    [Abstract] [Full Text] [Related]

  • 30. Vaccines: an innovative approach to treating cancer.
    Pazdur MP, Jones JL.
    J Infus Nurs; 2007 Jun 15; 30(3):173-8. PubMed ID: 17505219
    [Abstract] [Full Text] [Related]

  • 31. [Development for a novel cancer vaccine].
    Tsunoda T.
    Gan To Kagaku Ryoho; 2004 Dec 15; 31(13):2095-9. PubMed ID: 15628750
    [Abstract] [Full Text] [Related]

  • 32. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H, Shurin MR, Han B.
    Expert Rev Vaccines; 2007 Jun 15; 6(3):333-45. PubMed ID: 17542749
    [Abstract] [Full Text] [Related]

  • 33. Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy.
    van der Burg SH, Bijker MS, Welters MJ, Offringa R, Melief CJ.
    Adv Drug Deliv Rev; 2006 Oct 01; 58(8):916-30. PubMed ID: 16979788
    [Abstract] [Full Text] [Related]

  • 34. Therapeutic cancer vaccines.
    Srivastava PK.
    Curr Opin Immunol; 2006 Apr 01; 18(2):201-5. PubMed ID: 16464565
    [Abstract] [Full Text] [Related]

  • 35. GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development.
    Brichard VG, Lejeune D.
    Vaccine; 2007 Sep 27; 25 Suppl 2():B61-71. PubMed ID: 17916463
    [Abstract] [Full Text] [Related]

  • 36. The potential role of fowlpox virus in rational vaccine design.
    Beukema EL, Brown MP, Hayball JD.
    Expert Rev Vaccines; 2006 Aug 27; 5(4):565-77. PubMed ID: 16989636
    [Abstract] [Full Text] [Related]

  • 37. Therapeutic vaccines for prostate cancer: a review of clinical data.
    Arlen PM, Gulley JL.
    Curr Opin Investig Drugs; 2005 Jun 27; 6(6):592-6. PubMed ID: 15988910
    [Abstract] [Full Text] [Related]

  • 38. Prospects for vaccine therapy for pancreatic cancer.
    Gaudernack G.
    Best Pract Res Clin Gastroenterol; 2006 Apr 27; 20(2):299-314. PubMed ID: 16549329
    [Abstract] [Full Text] [Related]

  • 39. Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.
    Bellone S, Pecorelli S, Cannon MJ, Santin AD.
    Expert Rev Anticancer Ther; 2007 Oct 27; 7(10):1473-86. PubMed ID: 17944571
    [Abstract] [Full Text] [Related]

  • 40. A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease.
    Dessureault S, Noyes D, Lee D, Dunn M, Janssen W, Cantor A, Sotomayor E, Messina J, Antonia SJ.
    Ann Surg Oncol; 2007 Feb 27; 14(2):869-84. PubMed ID: 17103257
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.